FDA Inspection 1040682 — Jeffrey Ralph, M.D.

Jeffrey Ralph, M.D. — FEI 3013667410

The FDA completed an inspection of Jeffrey Ralph, M.D. on Feb 9, 2018 in San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Francisco, CA (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
751721 CFR 312.66Initial and continuing review
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.